Applied DNA Seeks New York Approval for H5 Bird Flu Test

MT Newswires Live
03-26

Applied DNA Sciences (APDN) said Wednesday that its Applied DNA Clinical Labs unit submitted a validation package to the New York State Department of Health for the approval of a test for the detection and subtyping on influenza A (H5) virus.

The influenza A (H5) virus, also known as H5 bird flu, is a highly pathogenic avian influenza, or H5N1, the company said.

The firm said its Linea Avian Influenza H5 Dx assay is a multi-target diagnostic assay capable of detecting and discriminating between pan-influenza A and H5 bird flu.

Price: 2.11, Change: +0.01, Percent Change: +0.48

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

no data

没有相关数据

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”